Successful islet transplantation to two recipients from a single donor by targeting proinflammatory cytokines in mice

Transplantation

Volumn 83, Issue 8, 2007, Pages 1085-1092

  Satoh, Masayuki ^a   Yasunami, Yohichi ^a   Matsuoka, Nobuhide ^a   Nakano, Masahiko ^a   Itoh, Takeshi ^a   Nitta, Tomoyuki ^a   Anzai, Keizo ^a   Ono, Junko ^a   Taniguchi, Masaru ^b   Ikeda, Seiyo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Engraftment; Islet transplantation; Proinflammatory cytokine

Indexed keywords

CD4 ANTIBODY; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 1BETA ANTIBODY; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CONTROLLED STUDY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; LIVER; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES;

ANIMALS; ANTIBODIES; CYTOKINES; DIABETES MELLITUS; DOWN-REGULATION; GLUCOSE; HYPERGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, KNOCKOUT; STREPTOZOCIN; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247476877     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000260161.81775.58     Document Type: Article

References (29)

1. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Ricordi C, Strom TB. Clinical islet transplantation: Advances and immunological challenges. Nature Rev Imunol 2004; 4: 259.
3. Ryan EA, Lakey JRT, Paty BW, et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148.
4. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039.
5. Ozmen L, Ekdahl KN, Elgue G, et al. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: Possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002; 51: 1779.
6. Contreras JL, Eckstein C, Smyth CA, et al. Activated protein C preserves functional islet mass after intraportal transplantation: A novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 2004; 53: 2804.
7. Taniguchi M, Harada M, Kojo S, et al. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003; 21: 483.
8. + cells mediates early graft loss of syngeneic transplanted islets. J Exp Med 2005; 20: 913.
9. -/- in activating apoptosis of hepatocytes. J Immunol 1997; 159: 1418.
10. Sutton R, McShane PM, Gray DWR, Morris PJ. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 1986; 42: 689.
11. Okeda T, Ono J, Takaki R, Todo S. Simple method for the collection of pancreatic islets by the use of Ficoll-Conray gradient. Endocrinol Jpn 1979; 26: 495.
12. Kemp CB, Knight MJ, Scharp DW, et al. Transplantation of isolated pancreatic islets into the portal vein of rats. Nature 1973; 244: 447.
13. + in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: Prevention of rejection with anti-IL-2Rβ monoclonal antibody treatment. Transplantation 1997; 64: 633.
14. Matsuda JL, Naidenko OV, Gapin L, et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 2000; 192: 741.
15. Von Herrath MG, Oldstone MBA. Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J Exp Med 1997; 185: 531.
16. Campbell IL, Iscaro A, Harrinson LC. IFN-γ and tumor necrosis factor-α cytotoxicity to murine islets of Langerhans. J Immunol 1988; 141: 2325.
17. Pukel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines, synegistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes 1988; 37: 133.
18. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocinol Metab 1990; 71: 152.
19. Thomas HE, Darwiche Corbett JA, Kay TWH. Interleukin-1 plus γ-interferon-induced pancreatic β-cell dysfunction is mediated by β-cell nitric oxide production. Diabetes 2002; 51: 311.
20. + CD8- thymocytes with specific lymphokine secretion. Eur J Immunol 1993; 23: 307.
21. Yoshimoto T, Paul WE. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994; 179: 1285.
22. Ueki M, Yasunami Y, Motoyama K, et al. The amelioration of hyperglycemia in streptozotocin-induced diabetic rats after the intraportal transplantation of an insufficient number of islets with nicotinamide treatment. Transplantation 1995; 60: 313.
23. Nagai T, Yasunami Y, Nagata N, et al. Amelioration of hyperglycemia in streptozotocin-induced diabetic rats receiving a marginal mass of islet grafts by an oral antidiabetic agent, troglitazone. Pancreas 1996; 13: 381.
24. Nakano M, Yasunami Y, Maki T, et al. Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts. Transplantation 2000; 69: 214.
25. Hanauer SB, Dassopoulos T. Evolving treatment strategies for inflammatory bowel disease. Annu Rev Med 2001; 52: 299.
26. Podolsky DJ. Medical progress. Inflammatory bowel disease. N Engl J Med 2002; 347: 417.
27. Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 2006; 355: 704.
28. Goldbach-Mansky R, Dailey NJ, Canna SW, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1βInhibition. N Engl J Med 2006; 355: 581.
29. Frouda T, Ricordi C, Baidala DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037.